We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Autoscope Q2 Earnings Fall 50% Y/Y as Revenues Drop Amid Product Shift
Read MoreHide Full Article
Shares of Autoscope Technologies Corporation (AATC - Free Report) have fallen 8.6% since the release of its second-quarter 2025 results, underperforming the S&P 500 index’s 0.5% growth. The stock has also lagged in the broader monthly trend, declining 7.9% against the S&P 500’s 2.1% advance.
Autoscope reported second-quarter 2025 revenues of $2.9 million, down 24% from $3.8 million in the same period last year. Royalty revenues, which have been the primary contributor, fell 24% year over year to $2.8 million, while product sales plunged 56% to $31,000. Net income came in at $0.8 million, or 14 cents per share, marking a 50% decline from $1.5 million, or 28 cents per share, in the prior-year quarter. The first half of 2025 reflected similar softness, with revenues down 27% to $5 million and net income falling 53% to $1.1 million, or 21 cents per share, compared with $2.4 million, or 44 cents per share, in the year-ago period.
Autoscope Technologies Corporation Price, Consensus and EPS Surprise
The gross margin improved to 98% in the second quarter from 95% a year earlier, driven by a perfect 100% royalty margin compared with 97% in the prior-year period. Product sales gross margin, however, deteriorated sharply to negative 61% from negative 1% in the second quarter of 2024. Operating expenses were flat year over year at $1.7 million for the quarter, but declined 5% to $3.4 million for the first half of 2025. On a non-GAAP basis, which excludes amortization and depreciation, operating income for the quarter was $1.2 million compared with $2.1 million a year earlier.
The company’s cash position rose to $2.4 million at the end of the quarter from $609,000 at the close of the first quarter of 2025, reflecting stronger operating cash flows. Year to date, operating activities generated $2.9 million in cash versus $1.3 million in the prior-year period, aided by working capital improvements and reduced operating expenses.
Management Commentary
Interim CEO Andy Markese attributed the decline in royalty revenues to both strategic and external factors. He cited a product transition, as agencies gradually adopt the Autoscope OptiVu platform, leading to a slowdown in sales of the legacy Autoscope Vision product line that has historically driven royalty revenues. Broader macroeconomic headwinds, including federal funding uncertainty and supply-chain impacts from Build America, Buy America requirements, also weighed on the company’s performance.
Markese also noted that late 2024 saw elevated royalty receipts from large distributor inventory purchases in anticipation of 2025 demand, which contributed to the current year’s lower royalty levels. Despite this, he expects Autoscope Vision royalties to remain among the top three years in the platform’s history. He emphasized that the company’s financial discipline and market experience position it well as OptiVu secures more qualified listing approvals and procurement timelines normalize.
Factors Influencing the Headline Numbers
The revenue contraction was primarily driven by a double-digit percentage drop in royalties, a direct result of transitioning customers to new product offerings and reduced legacy product sales. In addition, the challenging macroeconomic environment for infrastructure projects delayed procurement and pressured sales cycles. By maintaining tight cost controls, the company was able to offset some of the revenue pressure, keeping operating expenses stable quarterly and slightly lower over the first six months of 2025.
The improved gross margin largely resulted from a shift in the revenue mix toward royalties, which carry near-total profitability. However, product sales profitability weakened significantly, likely reflecting lower volumes, pricing pressures and potentially higher costs per unit sold.
Other Developments
The board of directors declared a quarterly cash dividend of 15 cents per share, payable Aug. 25, 2025, to shareholders of record as of Aug. 18, 2025. Additionally, the company recognized a deferred tax asset write-off of $119,000 tied to the planned dissolution of its Canadian entity, signaling a streamlining of its international corporate structure. No acquisitions or divestitures were disclosed in the quarter.
Management’s commentary suggested expectations for improved momentum as OptiVu adoption accelerates and agency procurement patterns stabilize. The emphasis remains on navigating the transition while capitalizing on long-term growth opportunities in intelligent transportation solutions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Autoscope Q2 Earnings Fall 50% Y/Y as Revenues Drop Amid Product Shift
Shares of Autoscope Technologies Corporation (AATC - Free Report) have fallen 8.6% since the release of its second-quarter 2025 results, underperforming the S&P 500 index’s 0.5% growth. The stock has also lagged in the broader monthly trend, declining 7.9% against the S&P 500’s 2.1% advance.
Autoscope reported second-quarter 2025 revenues of $2.9 million, down 24% from $3.8 million in the same period last year. Royalty revenues, which have been the primary contributor, fell 24% year over year to $2.8 million, while product sales plunged 56% to $31,000. Net income came in at $0.8 million, or 14 cents per share, marking a 50% decline from $1.5 million, or 28 cents per share, in the prior-year quarter. The first half of 2025 reflected similar softness, with revenues down 27% to $5 million and net income falling 53% to $1.1 million, or 21 cents per share, compared with $2.4 million, or 44 cents per share, in the year-ago period.
Autoscope Technologies Corporation Price, Consensus and EPS Surprise
Autoscope Technologies Corporation price-consensus-eps-surprise-chart | Autoscope Technologies Corporation Quote
Other Key Business Metrics
The gross margin improved to 98% in the second quarter from 95% a year earlier, driven by a perfect 100% royalty margin compared with 97% in the prior-year period. Product sales gross margin, however, deteriorated sharply to negative 61% from negative 1% in the second quarter of 2024. Operating expenses were flat year over year at $1.7 million for the quarter, but declined 5% to $3.4 million for the first half of 2025. On a non-GAAP basis, which excludes amortization and depreciation, operating income for the quarter was $1.2 million compared with $2.1 million a year earlier.
The company’s cash position rose to $2.4 million at the end of the quarter from $609,000 at the close of the first quarter of 2025, reflecting stronger operating cash flows. Year to date, operating activities generated $2.9 million in cash versus $1.3 million in the prior-year period, aided by working capital improvements and reduced operating expenses.
Management Commentary
Interim CEO Andy Markese attributed the decline in royalty revenues to both strategic and external factors. He cited a product transition, as agencies gradually adopt the Autoscope OptiVu platform, leading to a slowdown in sales of the legacy Autoscope Vision product line that has historically driven royalty revenues. Broader macroeconomic headwinds, including federal funding uncertainty and supply-chain impacts from Build America, Buy America requirements, also weighed on the company’s performance.
Markese also noted that late 2024 saw elevated royalty receipts from large distributor inventory purchases in anticipation of 2025 demand, which contributed to the current year’s lower royalty levels. Despite this, he expects Autoscope Vision royalties to remain among the top three years in the platform’s history. He emphasized that the company’s financial discipline and market experience position it well as OptiVu secures more qualified listing approvals and procurement timelines normalize.
Factors Influencing the Headline Numbers
The revenue contraction was primarily driven by a double-digit percentage drop in royalties, a direct result of transitioning customers to new product offerings and reduced legacy product sales. In addition, the challenging macroeconomic environment for infrastructure projects delayed procurement and pressured sales cycles. By maintaining tight cost controls, the company was able to offset some of the revenue pressure, keeping operating expenses stable quarterly and slightly lower over the first six months of 2025.
The improved gross margin largely resulted from a shift in the revenue mix toward royalties, which carry near-total profitability. However, product sales profitability weakened significantly, likely reflecting lower volumes, pricing pressures and potentially higher costs per unit sold.
Other Developments
The board of directors declared a quarterly cash dividend of 15 cents per share, payable Aug. 25, 2025, to shareholders of record as of Aug. 18, 2025. Additionally, the company recognized a deferred tax asset write-off of $119,000 tied to the planned dissolution of its Canadian entity, signaling a streamlining of its international corporate structure. No acquisitions or divestitures were disclosed in the quarter.
Management’s commentary suggested expectations for improved momentum as OptiVu adoption accelerates and agency procurement patterns stabilize. The emphasis remains on navigating the transition while capitalizing on long-term growth opportunities in intelligent transportation solutions.